FGFRL1 and neoplasm: Because FGFRL1 xenograft growth was strongly inhibited, the CASTIN analysis tool [40] was used to identify significantly enriched tumor–stroma interactions between receptors and cognate ligands, expressed specifically by mouse cells (stromal cells) and human tumor cells (PC3M cells).